Page last updated: 2024-10-29

nsc 664704 and Hepatitis B

nsc 664704 has been researched along with Hepatitis B in 1 studies

kenpaullone: inhibits CDK1/cyclin B; structure in first source
kenpaullone : An indolobenzazepine that is paullone in which the hydrogen at position 9 is replaced by a bromo substituent. It is an ATP-competitive inhibitor of cyclin-dependent kinases (CDKs) and glycogen synthase kinase 3beta (GSK3beta).

Hepatitis B: INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buchmann, B1
Döhner, K1
Schirdewahn, T1
Sodeik, B1
Manns, MP1
Wedemeyer, H1
Ciesek, S1
von Hahn, T1

Other Studies

1 other study available for nsc 664704 and Hepatitis B

ArticleYear
A screening assay for the identification of host cell requirements and antiviral targets for hepatitis D virus infection.
    Antiviral research, 2017, Volume: 141

    Topics: Antibodies, Monoclonal; Antiviral Agents; Automation; Benzazepines; Coinfection; Hepatitis Antibodie

2017